Patients with periodic breathing, e.g., Cheyne-Stokes respiration, or central, mixed or complex sleep-disordered breathing, are treated quickly and reliably by the newly validated algorithm in prismaCR. At the heart of the
algorithm is a backup frequency based on the target volume combined with intrabreath regulation. It provides need-oriented pressure support during the current breath, a technology called Anticyclic Servoventilation (AcSV) that
is Made in Germany.
Therapy Effective
- Validated Anticyclic Servoventilation (AcSV) reacts quickly with a smart adaptation of pressure support within a breath
- Many possibilities: Extensive pressure range (4 to 30 hPa) and many parameters for more flexibility in therapy settings
- Precise: Identification of periodic breathing, RERA, snoring, hypopnea, apnea and flow limitations
- Flexible: Dynamic increase in pressure support depending on the intensity of preceding hyperventilation
- Mild: Gentle reaction to non-periodic disordered breathing, as during REM sleep
- Proven: Optionally with autoTRILevel principle and autoEEPAP regulation
- Quick configuration: SCOPEs for indication-related pre-settings with the option for adjustment
Processes
- Good overview: High-resolution therapy data for 14 days and detailed statistics for 366 days
- Process support: With SD card and USB port
- Uncomplicated: Eight clearly distinguished analog signals for PSG feed
- Practical: Remote management (prismaLAB) via LAN with therapy software prismaTS
- Worry-free: No-maintenance prismaLINE
Comfort
- High compliance: Thanks to comfort functions such as soft-start, autoSTART-STOP and continuous mask, and therapy feedback
- Best conditions: heated breathing tube Prisma HYBERNITE warms the air and stops condensation from forming in the tube, thereby preventing annoying mask sounds.
- Especially simple: The easy-to-use humidifier prismaAQUA
